Ixodes ricinus is the most important ectoparasite in Europe, responsible for the transmission of several pathogens. The characteristics of the tick bite (e.g. absence of immediate symptoms) imply the possibility that part of the infections transmitted by ticks remain occult. lt is thus difficult to estimate the actual impact of ticks on the health of human and animai populations. A tool capable of determining whether humans/animals have been bitten by I. ricinus would allow to: determine the actual 'pressure' of the tick bite; estimate the risk associated with tick parasitism; contribute to the diagnosis of diseases such as the Lyme disease, where anamnestic information is frequently lacking. With the goal of developing markers for the 'diagnosis' of the I. ricinus bite, we first focused on Midichloria mitochondrii, a bacterium present in all the infecting stages of I. ricinus, reaching 100% prevalence in adult females, where it is also observed in the salivary glands. Humans and animals exposed to I. ricinus present an antibody response against a recombinant flagellar protein (rFLID). rFliD might thus represent an antigen for the serological evaluation of the exposure to the tick. Seroprevalence for Midichloria rFliD in humans exposed to I. ricinus ranges from 30 to 60%. Thus, rFliD appears promising, but incapable of determining the exposure to I. ricinus in approximately 50% of the patients. We initiated a seroproteomic work on /. ricinus and Midichloria proteins, with the goal of detecting further antigens. Using sera from patients parasitized, collected at the tick removal and after 40-60 days, we characterized additional proteins that determined seroconversion. Work is in progress to develop peptides from the discovered antigens, in order to set-up an ELISA-assay for a first applicat1on and validation of this serological tool, on a wide panel of subjects exposed at a different risk of tick parasitism.
Estimating the risk associated with Ixodes ricinus parasitism: towards the development of serological markers for the tick bite / C. Bazzocchi, A. Cafiso, M. Di Venere, V. Serra, C. Bandi, P. Iadarola, D. Sassera - In: International Symposium on Tick-Borne Pathogens and Disease[s.l] : Austrian Society for Hygiene, Microbiology and Preventive Medicine (OGHMP), 2017. - pp. 11-11 (( convegno International Symposium on Tick-Borne Pathogens and Disease (ITPD) tenutosi a Wien nel 2017.
Estimating the risk associated with Ixodes ricinus parasitism: towards the development of serological markers for the tick bite
C. Bazzocchi;A. Cafiso;V. Serra;C. Bandi;
2017
Abstract
Ixodes ricinus is the most important ectoparasite in Europe, responsible for the transmission of several pathogens. The characteristics of the tick bite (e.g. absence of immediate symptoms) imply the possibility that part of the infections transmitted by ticks remain occult. lt is thus difficult to estimate the actual impact of ticks on the health of human and animai populations. A tool capable of determining whether humans/animals have been bitten by I. ricinus would allow to: determine the actual 'pressure' of the tick bite; estimate the risk associated with tick parasitism; contribute to the diagnosis of diseases such as the Lyme disease, where anamnestic information is frequently lacking. With the goal of developing markers for the 'diagnosis' of the I. ricinus bite, we first focused on Midichloria mitochondrii, a bacterium present in all the infecting stages of I. ricinus, reaching 100% prevalence in adult females, where it is also observed in the salivary glands. Humans and animals exposed to I. ricinus present an antibody response against a recombinant flagellar protein (rFLID). rFliD might thus represent an antigen for the serological evaluation of the exposure to the tick. Seroprevalence for Midichloria rFliD in humans exposed to I. ricinus ranges from 30 to 60%. Thus, rFliD appears promising, but incapable of determining the exposure to I. ricinus in approximately 50% of the patients. We initiated a seroproteomic work on /. ricinus and Midichloria proteins, with the goal of detecting further antigens. Using sera from patients parasitized, collected at the tick removal and after 40-60 days, we characterized additional proteins that determined seroconversion. Work is in progress to develop peptides from the discovered antigens, in order to set-up an ELISA-assay for a first applicat1on and validation of this serological tool, on a wide panel of subjects exposed at a different risk of tick parasitism.File | Dimensione | Formato | |
---|---|---|---|
Bazzocchi et al_ITPD_2017.pdf
accesso aperto
Descrizione: Abstract Presentazione Congresso ITPD Bazzocchi et al 2017
Tipologia:
Publisher's version/PDF
Dimensione
201.2 kB
Formato
Adobe PDF
|
201.2 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.